Eloxx Pharmaceuticals, Inc. · NASDAQ:ELOX
Srinivas Akkaraju reported a 9.90% stake in Eloxx Pharmaceuticals, Inc. (Schedule 13G)
Event Jun 10, 2026 · Filed Aug 14, 2026
Srinivas Akkaraju reported a 9.90% stake in Eloxx Pharmaceuticals, Inc., 403,586 shares, as a passive investor on Jun 10, 2026. Filed Aug 14, 2026 (Schedule 13G).
- Stake
- 9.90%
- Shares
- 403,586
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Samsara BioCapital, L.P. | 5.00% | 201,793 |
| Samsara BioCapital GP, LLC | 5.00% | 201,793 |
| Samsara Opportunity Fund, L.P. | 5.00% | 201,793 |
| Samsara Opportunity Fund GP, LLC | 5.00% | 201,793 |
| Srinivas Akkaraju | 9.90% | 403,586 |
Source
Related
- Eloxx Pharmaceuticals, Inc.
- Srinivas Akkaraju
- Eloxx Pharmaceuticals, Inc. shareholders
- Schedule 13G · Nantahala Capital Management, LLC · Aug 14, 2026
- Schedule 13G · Domicilium Capital Partners LLC · Jun 17, 2026
- Schedule 13G · EcoR1 Capital, LLC · Jun 16, 2026
- Schedule 13G · Stonepine Capital Management, LLC · Jun 16, 2026
- Schedule 13G · Invus Public Equities, L.P. · Jun 15, 2026